alexa Abstract | The value of contrast-enhanced computed tomography in evaluating patient response to icotinib for non-small cell lung cancer

Biomedical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

We aimed to evaluate the value of contrast-enhanced Computed Tomography (CT) imaging in analyzing the therapeutic effects of icotinib for Non-Small Cell Lung Cancer (NSCLC). Forty-five patients with histologically proven NSCLC underwent contrast-enhanced CT scanning before and after therapy with icotinib. All the data were automatically analyzed, and changes in each parameter before and after therapy were compared. According to the therapeutic response based on the Response Evaluation Criteria in Solid Tumors and 3-month follow-up evaluations, 26 of 45 patients received effective treatment and 19 patients who received ineffective treatment. The mean density and enhancement extent of lesions were not statistically different before treatment in patients who received effective treatment or in those who received ineffective treatment (P>0.05). After treatment, the mean density and enhancement extent of lesions for the 26 patients who received effective treatment were significantly reduced as compared to their respective pretreatment values (P=0.000). No significant difference was detected in any parameter before and after treatment for the 16 patients who received ineffective treatment (P>0.05). The mean density and enhancement extent of lesions in patients who received effective treatment were significantly decreased as compared to those who obtained ineffective treatment (P<0.05). In addition to size changes, tumor density, the degree of enhancement, and cavity changes found on contrast-enhanced CT scans were each associated with treatment response. Contrast-enhanced CT scans have significant value in determining the effect of icotinib in NSCLC patients.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Jinping Yu Haixia Liu Hong Chen Shuhua Ren

Keywords

Contrast-enhanced CT, Non-small-cell lung cancer, Icotinib, Effect evaluation, #

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords